, /PRNewswire/ -- Via Scientific, Inc., a caller Cambridge based exertion and AI company, is arrogant to denote the motorboat of Foundry, a multi-omics accelerator level focused connected importantly shortening the way to technological breakthroughs.
The Foundry level was primitively developed astatine UMass Chan Medical School; Via Scientific has exclusive commercialized rights to the platform. Founders of the institution are Melissa J. Moore, PhD Chief Scientific Officer Emeritus astatine Moderna, Alper Kucukural, PhD co-director of the Bioinformatics Core astatine UMass Chan Medical School and CTO of Via Scientific, Manuel Garber, PhD, co-director of the Bioinformatics Core astatine UMass Chan Medical School, Jim Crowley, section exertion and AI entrepreneur and Janet Kosloff, laminitis of the wellness attraction analytics institution InCrowd, Inc.
Foundry automates the analyzable information and analytical enactment associated with multi-omics research. Featuring a almighty drag-and-drop pipeline and meta information gathering functionality that eliminates the request to constitute code, positive afloat process orchestration and customizable analytics, Foundry is simply a unit multiplier for biomedical researchers. Furthermore, the level ensures that each information and analytics are shareable, reusable, and reproducible. This frees up clip and resources for some investigators and bioinformaticians to ore connected generating halfway technological insights and therapeutic breakthroughs.
"We are thrilled to present Foundry to the market," said Melissa Moore. "As some an academician and CSO astatine Moderna, I saw firsthand the request for a almighty and adaptable instrumentality similar Foundry. Scientists are consistently challenged to support up with our quality to inquire questions and ideate possibilities. Foundry transforms 'process time' into 'scientific time', truthful technological teams tin absorption connected unlocking the underlying subject that results successful caller insights and breakthroughs."
"Multi-omics analytics is maddingly difficult, and we person made it our ngo to simplify this captious probe domain," added Jim Crowley, CEO of Via Scientific. "Scientists should not person to walk their clip wrangling data, penning code, and coordinating dev. op. tasks conscionable truthful they tin get to the constituent wherever they tin statesman to inquire their questions. Foundry changes each of that arsenic scientists volition present walk their clip wherever it is intended - interrogating experimental results, shaping insights, and advancing understanding."
Via Scientific is focused connected supporting the analytical needs of biotech, pharmaceutical, probe institutes and world universities, and connected further processing the Foundry level and amplifying its AI capabilities.
About Via Scientific: Via Scientific, Inc., is a Cambridge, Massachusetts-based bioinformatics and analytics exertion company. The Company was founded successful 2022 and was publically launched successful February 2023 aft a twelvemonth successful stealth mode. The company's Foundry platform, disposable some connected Cloud and arsenic an on-premises solution, radically simplifies endeavor standard multi-omics and analytics. Via Scientific is rapidly increasing and individuals with bonzer engineering, AI and bioinformatic skills tin scope the Company astatine [email protected]. Learn much astatine www.viascientific.com.
About UMass Chan Medical School
UMass Chan Medical School, 1 of 5 campuses of the University of Massachusetts system, comprises the T.H. Chan School of Medicine; the Morningside Graduate School of Biomedical Sciences; the Tan Chingfen Graduate School of Nursing; Commonwealth Medicine, a nationalist work consulting division; and MassBiologics, the lone nonprofit, FDA-licensed shaper of vaccines, biologics and viral vector cistron therapies successful the United States. UMass Chan's ngo is to beforehand the wellness and wellness of our divers communities passim Massachusetts and crossed the satellite by starring and innovating successful education, research, wellness attraction transportation and nationalist service. In doing so, it has built a estimation arsenic a world-class probe instauration and arsenic a person successful superior attraction education, perennially ranked successful the apical 10 percent of aesculapian schools for superior attraction by U.S. News and World Report. UMass Chan attracts much than $300 million annually successful probe funding, placing it among the apical 50 aesculapian schools successful the nation. In 2021, the Medical School received a $175 million donation from The Morningside Foundation and was renamed UMass Chan Medical School.
SOURCE Via Scientific, Inc.
English (US)